The Complete GLP-1 Weight Loss Guide
A physician-reviewed guide to GLP-1 medications — how they work, what clinical trials show, who qualifies, and how to access semaglutide and tirzepatide through a physician-supervised online program.
· DietsMD Editorial Team · 16 min read
Medically reviewed by DietsMD Board-Certified Physicians specializing in obesity medicine and metabolic health.
Quick Answer
GLP-1 medications are prescription drugs that suppress appetite, slow digestion, and regulate blood sugar by mimicking a naturally occurring gut hormone. FDA-approved options for weight loss include semaglutide (Wegovy®, ~15% avg. weight loss) and tirzepatide (Zepbound®, ~20–22% avg. weight loss). Both are available through physician-supervised online programs with home delivery.
In This Guide
What Are GLP-1 Medications?
GLP-1 medications are a class of prescription drugs that mimic GLP-1, a hormone naturally produced in the gut after eating. GLP-1 plays a central role in regulating appetite, digestion, and blood sugar.
Originally developed to treat type 2 diabetes, GLP-1 receptor agonists were found to produce significant weight loss as a secondary effect, leading to FDA approvals for semaglutide (2021) and tirzepatide (2023) as chronic weight management medications.
How GLP-1 Medications Work
Appetite Suppression
GLP-1 receptors in the hypothalamus regulate hunger and satiety. When activated, these receptors reduce hunger signals — helping patients feel full sooner and remain satisfied longer between meals.
Slower Gastric Emptying
GLP-1 medications slow the rate at which food moves from the stomach into the small intestine, prolonging fullness and reducing glucose absorption speed.
Blood Sugar Regulation
GLP-1 medications stimulate insulin secretion and suppress glucagon release in a glucose-dependent manner, reducing post-meal blood sugar spikes without causing hypoglycemia in non-diabetic patients.
Reduced Reward-Driven Eating
Emerging research suggests GLP-1 medications may act on brain reward pathways, reducing the appeal of high-calorie foods and compulsive eating behaviors.
FDA-Approved GLP-1 Medications for Weight Loss
Semaglutide (Wegovy®)
Mechanism: GLP-1 receptor agonist
Avg. weight loss: ~15% body weight (STEP-1)
Dosing: Once weekly injection, up to 2.4 mg
FDA approved: 2021
Also notable: SELECT trial — 20% reduction in cardiovascular events
Full semaglutide guide →Tirzepatide (Zepbound®)
Mechanism: Dual GIP + GLP-1 receptor agonist
Avg. weight loss: ~20–22% body weight (SURMOUNT-1)
Dosing: Once weekly injection, up to 15 mg
FDA approved: 2023
Also notable: Highest avg. weight loss of any approved medication
Full tirzepatide guide →| Feature | Semaglutide | Tirzepatide |
|---|---|---|
| Mechanism | GLP-1 agonist | GLP-1 + GIP dual agonist |
| Brand (weight loss) | Wegovy® | Zepbound® |
| Avg. weight loss | ~15% | ~20–22% |
| FDA approval | 2021 | 2023 |
| Dosing | Once weekly | Once weekly |
| CV benefit data | Yes (SELECT trial) | Ongoing (SURMOUNT-MMO) |
| Compounded available | Yes | Yes |
Clinical Trial Results
Semaglutide: STEP Trial Program
- STEP-1: Adults with obesity lost an average of 14.9% of body weight over 68 weeks vs. 2.4% with placebo. 68% lost ≥10% of body weight.
- SELECT: Semaglutide reduced major adverse cardiovascular events by 20% — the first weight loss medication to receive this FDA indication.
Tirzepatide: SURMOUNT Trial Program
- SURMOUNT-1: Adults with obesity lost an average of 20.9% of body weight at the 15 mg dose over 72 weeks. 37% lost ≥25% of body weight.
- SURMOUNT-4: Patients who discontinued tirzepatide regained approximately two-thirds of lost weight within 52 weeks.
Ready to Explore GLP-1 Treatment?
DietsMD board-certified physicians evaluate your health history and recommend the most appropriate GLP-1 medication for your goals. Confidential. No pressure.
Who Qualifies for GLP-1 Weight Loss Medications?
- BMI of 30 or greater (obesity), OR
- BMI of 27 or greater with at least one weight-related condition
- No personal or family history of MTC or MEN2
- Not pregnant or planning to become pregnant
Side Effects and Safety
Common Side Effects
- Nausea — most common, especially in the first weeks
- Vomiting, diarrhea, constipation, abdominal discomfort, fatigue
Serious Risks (Rare)
- Thyroid C-cell tumors: Contraindicated in patients with history of MTC or MEN2
- Pancreatitis: Rare; discuss history with physician
- Gallbladder disease: Rapid weight loss can increase gallstone risk
How to Access GLP-1 Treatment Online
- Complete a medical intake form. Provide your health history, medications, weight history, and goals.
- Physician consultation. A board-certified physician determines whether semaglutide or tirzepatide is appropriate.
- Prescription issued. Sent to a licensed U.S. pharmacy.
- Discreet home delivery. Shipped directly to your home.
- Ongoing monitoring. Regular physician check-ins throughout treatment.
Choosing the Right GLP-1 Program
When evaluating GLP-1 providers, patients often compare multiple platforms before starting. See how DietsMD compares to leading programs in our online weight loss program alternatives guide.
What to Look For
- Board-certified physician required before prescribing
- Comprehensive medical intake and eligibility screening
- Transparent, all-inclusive pricing with no hidden fees
- Ongoing physician monitoring and dose titration
- Licensed U.S. pharmacy fulfillment (503A or 503B for compounded)
- HIPAA-compliant platform
Red Flags to Avoid
- No physician consultation required before prescribing
- Medications from overseas or unverified pharmacies
- Guaranteed weight loss claims
- No follow-up or monitoring after the initial prescription
Start Your GLP-1 Weight Loss Journey
DietsMD connects you with board-certified physicians who specialize in semaglutide and tirzepatide programs. Transparent pricing. Discreet delivery. Ongoing support.
Frequently Asked Questions About GLP-1 Medications
GLP-1 stands for glucagon-like peptide-1, a hormone naturally produced in the gut after eating that regulates appetite, digestion, and blood sugar.
Tirzepatide has demonstrated the greatest average weight loss (~20-22%) vs. semaglutide (~15%). The best choice depends on your health history and physician recommendation.
GLP-1 medications suppress appetite, slow gastric emptying, and reduce food cravings, leading to sustained caloric reduction and significant weight loss.
GLP-1 medications have a favorable safety profile for most patients based on large clinical trials. Common side effects are gastrointestinal and typically mild. They are contraindicated in patients with MTC or MEN2 history.
GLP-1 medications are typically long-term treatments. Patients who stop often regain significant weight within 12 months.
Yes. Many patients use telehealth programs with self-pay pricing and compounded formulations, typically ranging from $200 to $600 per month.
GLP-1 and GIP are both gut hormones. Semaglutide targets GLP-1 receptors only. Tirzepatide targets both GLP-1 and GIP receptors (dual agonist), producing greater weight loss.
Compounded GLP-1 medications from accredited U.S. pharmacies (503A or 503B) are legal when prescribed by a licensed physician. Always confirm pharmacy accreditation.
Start with a medical consultation at DietsMD. Complete a confidential online intake and schedule a telehealth consultation with a board-certified physician.
Looking at other options? Browse our complete guide to the best online weight loss program alternatives — including comparisons to Ro, Hims & Hers, Found, Mochi Health, Noom Med, Calibrate, WeightWatchers Clinic, Henry Meds, Remedy Meds, Sesame, Eden, and Teladoc Health.
